Priming the translational pipeline for hemostasis therapies

One of the most important aspects of any ISTH congress is the coincident attendance and participation of basic scientists and clinicians, all of whom have interests in advancing knowledge of the biology and pathology of the hemostatic system. This mix of professionals ensures that conversations and ideas are shared between individuals who view the world of hemostasis through different lenses. Inevitably, these interactions often result in exciting new initiatives and outcomes.